Life Science Nation Announces Free Webinar Series In Preparation for RESI JPM

By Karen Deyo, VP of Product, Israel BD, LSN

Life Science Nation (LSN) is happy to announce our webinar schedule leading up to our next RESI conference, taking place in San Francisco, during JP Morgan Healthcare week. Featuring educational content put together by LSN to help early-stage startups with their fundraising campaigns, these webinars were designed to give companies the benefit of our experience, of working with startups and investors in the healthcare space for over a decade. This webinar series will also include a new session, and a fireside chat with investors with new funds who will be joining our LSN network. Make sure to mark these webinars on your calendars!

Tuesday, November 14, 12PM ET

Preparing for the Innovator’s Pitch Challenge (IPC) at RESI JPM – Sign Up

Maximizing your exposure to investors is critical to a successful fundraising campaign, and participating in pitch events plays a large role in that. The RESI Innovator’s Pitch Challenge has been designed to give companies a platform to promote their companies, practice their pitch, and get feedback from a panel of relevant investors and industry experts. Join this session to learn what you can gain from participating in the IPC and how to apply.


Tuesday, November 21, 12PM ET

Startup CEOs Global Partnering Strategy – Sign Up

This session will cover some of the pitfalls that catch first-time and serial entrepreneurs off guard. From false premise and being tentative to surrounding yourself with executives who do not have augmentative and complimentary skillsets, many things can slow the growth of your early-stage life science entity. By learning how to avoid these issues and not run yourself over, your chances of making it to the market will increase greatly.


Tuesday, November 28, 12PM ET

Presenting to Investors: Compelling Story VS. Pitch Deck – Sign Up

The most successful entrepreneurs are always the best storytellers. Finding a way to formulate your company’s unique story naturally and portraying this through multiple modalities whether it be a 1-minute elevator pitch or a 12-slide pitch deck is one of the most effective ways to get potential investors and partners on board with your value proposition. This bootcamp will cover the importance of entrepreneurial agency, finding your voice and developing a compelling narrative for the different players that will emerge along a deal chain, and language tools to refine your hook.


Tuesday, December 5, 12PM ET

Partnering Tutorial – Sign Up

Understanding the RESI partnering system and using it to its maximum capabilities can make a large difference in a company’s success at RESI. Join LSN staff as we walk you through our system and how it can help you identify partners who are a best fit for you, how to manage your outreach, our recommended strategy for following up, and how to take advantage of all of the content that we provide to ensure your best possible RESI experience.


Tuesday, December 12, 12PM ET

Fireside Chat with Three New Startups Funds – Sign Up

This Fireside Chat will feature investors representing new funds focusing on early-stage life science companies. Find out more about these funds joining the LSN ecosystem


Tuesday, December 19, 12PM ET

Partnering Tutorial – Sign Up

Understanding the RESI partnering system and using it to its maximum capabilities can make a large difference in a company’s success at RESI. Join LSN staff as we walk you through our system and how it can help you identify partners who are a best fit for you, how to manage your outreach, our recommended strategy for following up, and how to take advantage of all of the content that we provide to ensure your best possible RESI experience.


Wednesday, January 3, 12PM ET

Developing Your Global Target List of Investors For RESI JPM – Sign Up

Find tools to aid in your search for investors to reach out to who are a fit based on your company type.

RESI-SF-2024-Banner-1100

Hot Investor Mandate: Europe Based Venture Capital Firm with Multiple Funds Under Management Invests Across Healthcare Sectors, Including Digital Health, Diagnostics, Medical Devices and More in the US, Europe and Israel

A venture capital firm was founded in 1997 and operates offices in Berlin, Munich, Istanbul, and London. With EUR 2 billion under management across all fund streams, 9 IPOs, and 31 trade sales, the firm is one of Europe’s most established and active venture capital firms. Its dedicated Health Fund leads or co-leads investments, typically with an initial investment of €4-6 million and an average of €6-12 million per company over the lifetime of the investment. The geographical focus is on companies across Europe and selectively in the US and Israel.

The firm focuses on technologies across healthcare sectors, including digital health, diagnostics, medical devices, R&D tools and biopharma, with the ultimate goal of delivering strong, positive patient outcomes.

The firm is open to investing in companies at early stages with proof-of-concept, clinically relevant data and/or strong IP positions.

If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.

Hot Investor Mandate: Hong Kong Life Science Venture Capital Firm Seeks Therapeutics and Medical Devices Opportunities Globally, with Focuses on Oncology, Immunology, Metabolic and CNS Diseases

A life sciences venture capital fund founded in 2014 with an office in Central, Hong Kong currently manages three funds with ~ $600 million assets under management, and is actively seeking investment opportunities. On average, the size of investment is $5-25M in venture rounds. The firm prefers to act as the lead investor but is also open to co-investing. The firm looks for companies located around the globe, with a preference in the US and China. The firm is actively seeking new investment opportunities.

The firm is focused on Therapeutics and Medical Devices opportunities. The core focused therapeutic areas include oncology, immunology, metabolic and CNS diseases, but the firm is also focused on new modalities and platform technologies. The firm is also interested in interventional, novel medical devices in cardiovascular, neuro-vascular & lung diseases.

The firm prefers a management team with strong scientific background and expertise, successful track records would be a plus but is not required. The firm generally takes a board seat.

If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.

Hot Investor Mandate: New York Based Venture Capital Firm Invests in Series A and Beyond, Looking for Healthcare Services, Digital Health and Medical Devices Companies that Targets Unmet Needs or Underserved Communities

A venture capital firm was founded in 2022 and based in New York, New York. Fund I of $100M USD, dedicated towards opportunities starting at Series A rounds. The typical investment size ranges from 5mm – 10mm and the firm expects to invest in 2-3 companies in the next year. The firm focuses on opportunities in the United States and territories. The firm invests in innovative healthcare companies that demonstrate the potential to increase accessibility, improve outcomes, and reduce costs, ultimately contributing to the advancement of sustainable and equitable healthcare solutions.

The firm focuses on unmet needs and underserved communities. The firm primarily looks at services, digital health, medical devices, all through a policy lens, and does not consider pharmaceuticals. Within medical devices, the firm is interested in software enabled devices in development phases. The firm is opportunistic within the digital health sector. While the firm is open to all indications, areas with unmet needs (women’s health) are of interest.

The firm does not have any requirements of the management team. The firm will both lead and co-lead investments and require board seating.

If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.

Hot Investor Mandate: US Private Investment Firm Invests in Digital Health and Medical Technologies with Software Component, Prefers Founding Team with Both Technical and Business Expertise

An early-stage private investment firm is based in Silicon Valley, CA. The initial investments are typically $25,000-$100,000 and the firm can scale investments from there. The firm also provides select startups with business development support through a no-fee program. The firm will consider investing in companies worldwide.

The firm is interested in investing in digital health and medical technology and invests in subsectors in which the firm and its industry partners can apply expertise; within medical devices, typically this means products that have a significant software component, including biosensors, wearables, and health monitoring devices. Within digital health, the firm’s  interests include: Care Management, Hospital Workflow, Diagnostics, A.I. & Big Data, Population Health, and Patient Adherence. The firm prefers B2B business models.

The firm prefers to invest in companies with at least two co-founders, one with technical expertise and one with business expertise. In addition to due diligence on the management team and technology, the firm also considers a product’s potential market opportunity.

If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.

Important Deadlines Are Approaching

By Cameron Hurlburt, Manager of Business Development – West Coast (US), LSN

It is officially November and some key deadlines for attending Life Science Nation (LSN) ‘s flagship RESI conference, in January of the new year, RESI JPM, are approaching. LSN wants to make sure our community takes advantage of the opportunities to save, pitch, and prepare for partnering meetings to start 2024 on the right track. Mark your calendars:

1. Price Increase on November 17

Register by November 17 and save $300 with early bird rates. Join RESI JPM 2024 – the largest early-stage life sciences partnering event of the year at Marine’s Memorial Club & Hotel in San Francisco on January 9 during the annual JPM healthcare conference week. If you are fundraising, this is your chance to make compelling connections and kickstart fundraising campaign.

Register-now-button-new

2. Innovator’s Pitch Challenge Deadline is November 22

The application deadline to apply is November 22. The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage life science and healthcare companies to gain additional exposure to conference attendees and pitch directly to a panel of judges, featuring active investors and industry experts. The slots are filled on a first come, first served basis so we highly encourage early application submissions!

3. Partnering Launches on December 4

Registering for RESI JPM early ensures you will be among the first attendees to access the RESI Partnering System. The RESI Partnering Platform helps you find non-traditional partners from the newest sources of capital, including family offices, foundations, academic institutions, philanthropic organizations, and some of the hottest emerging biotech and medtech companies worldwide. If you are looking to take your partnering to the next level, consider adding the premier package to increase your access to investor profiles ($500). Premier partnering grants you access to investor mandates in the LSN Investor Database, which includes direct emails to support your target list and facilitate year-round connection.

 WHAT TO EXPECT AT RESI JPM 2024

LSN will host 500+ early-stage life Science investors and strategic partners, 500+ early-stage life science start-ups & fundraising executives, and 200+ service providers including CROs/CMOs, Tech Hubs, and Regional Organizations.

There are 100+ partnering meeting slots per attendee during the 3-day hybrid conference with additional ad-hoc meeting opportunities. Registered in-person attendees have access to    14+ Investor Panels, Workshops, and Entrepreneurial Education Classes and 50+ In-person Pitch Slots with 14 Pitch Sessions in RESI Innovator’s Pitch Challenge

Have any questions? Feel free to contact us!

RESI-SF-2024-Banner-1100

Medical Device Panel at RESI JPM 2024

By Joey Wong, Senior Investor Research Analyst, Hong Kong BD, LSN

The panel recruitment for RESI JPM, taking place in-person on January 9, 2024, has exceeded our expectations, and we are happy to announce the full lineup of the Medical Devices Investors Panel. This popular RESI panel will host an insightful conversation on forward-looking trends in medical device innovations. The participating panelists are a diverse and international representation of speakers at this RESI. By bringing together active investors and strategics with various backgrounds, RESI aims to bridge the gap between investors and fundraising entrepreneurs, fostering a platform for open communications between the buy side and sell side.

Final - Medical Devices Panel JPM24

In addition to the Medical Device Panel, LSN’s investor research team has curated a program of panels, covering a wide range of topics highly relevant to early-stage life science and healthcare innovators. Each panel will feature active investors and key strategic partners to share their knowledge based on extensive industry experiences.

Some of the panels will explore various sectors of interest, such as therapeutics, or emerging areas like mental and behavioral health. Speakers will discuss their insights on the investment landscape, future trends, and opportunities specific to these sectors or indication areas. Other panels are geared towards distinct types of industry players or investment groups that play an important strategic role in the ecosystem, such as large pharmaceutical companies, health system partners, and cross-border investment groups. These panels will delve into the strategic roles these organizations play within the ecosystem, what they are looking for in the sector, things to consider, and how companies can partner with groups like themselves.
RESI-SF-2024-Banner-1100